文献速递间质性肺疾病呼吸道感染

SARS-CoV-2疫苗接种后间质性肺疾病急性加重:病例系列

Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination: A Case Series.
PubMed 文献 · Chest · 2022-01-01

本文报告3例间质性肺疾病(ILD)患者在接种SARS-CoV-2 mRNA疫苗后出现急性呼吸衰竭。3例均为男性,平均年龄77岁,吸烟史10–30包年。呼吸衰竭发生于接种后1天(2例)和9天(1例)。1例尸检显示弥漫性肺泡损伤叠加普通型间质性肺炎,另2例CT示弥漫磨玻璃影和胸膜下网格影,提示ILD急性加重。2例经大剂量甲泼尼龙治疗成功。尽管疫苗接种获益大于不常见不良事件风险,慢性肺病患者接种后应密切观察。

要点

  • ILD患者接种SARS-CoV-2 mRNA疫苗后可能发生急性呼吸衰竭,需警惕。
  • 呼吸衰竭可在接种后1天或9天出现,CT示弥漫磨玻璃影和胸膜下网格影。
  • 部分病例经大剂量甲泼尼龙治疗成功,但需密切观察慢性肺病患者。

核心结论

  • ILD患者接种SARS-CoV-2 mRNA疫苗后可能发生急性加重,表现为急性呼吸衰竭。

研究设计与样本

  • 病例系列,报告3例ILD患者接种SARS-CoV-2 mRNA疫苗后出现急性呼吸衰竭。

主要发现

  • 3例均为男性,平均年龄77岁,吸烟史10–30包年。
  • 呼吸衰竭发生于接种后1天(2例)和9天(1例)。
  • 1例尸检示弥漫性肺泡损伤叠加普通型间质性肺炎。
  • 另2例CT示弥漫磨玻璃影和胸膜下网格影,提示ILD急性加重。
  • 2例经大剂量甲泼尼龙治疗成功。

临床怎么用

  • 慢性肺病患者接种SARS-CoV-2疫苗后应密切观察。
  • ILD患者接种后出现呼吸衰竭需考虑急性加重,CT和病理可辅助诊断。
  • 大剂量甲泼尼龙可用于治疗此类急性加重。

局限性

  • 仅3例病例系列,无法确立因果关系。
  • 部分病例缺乏病理证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An acute exacerbation of interstitial lung disease (ILD) is an acute deterioration that can occur at any time and is associated with significant morbidity and mortality rates. We herein report three patients with ILD who experienced acute respiratory failure after SARS-CoV-2 messenger RNA vaccination. All the patients were male; the mean age was 77 years. They had a smoking history that ranged from 10 to 30 pack-years. Duration from the vaccination to the onset of respiratory failure was 1 day in two patients and 9 days in one patient. In an autopsied case, lung pathologic evidence indicated diffuse alveolar damage superimposed on usual interstitial pneumonia. In the other two cases, CT scans showed diffuse ground-glass opacities and subpleural reticulation, which suggests acute exacerbation of ILD. Two patients were treated successfully with high-dose methylprednisolone. Although benefits of vaccination outweigh the risks associated with uncommon adverse events, patients with chronic lung diseases should be observed carefully after SARS-CoV-2 vaccination.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ishioka Y, Makiguchi T, Itoga M, et al. Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination: A Case Series. Chest. 2022. PMID: 36494131. doi:10.1016/j.chest.2022.08.2213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。